Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis

Larry Yang, Bruce G. Link, Shelly Ben-David, Kelly E. Gill, Ragy R. Girgis, Gary Brucato, Ahtoy J. Wonpat-Borja, Cheryl M. Corcoran

Research output: Contribution to journalArticle

Abstract

Background: Despite advances that the psychosis "clinical high-risk" (CHR) identification offers, risk of stigma exists. Awareness of and agreement with stereotypes has not yet been evaluated in CHR individuals. Furthermore, the relative stigma associated with symptoms, as opposed to the label of risk, is not known, which is critical because CHR identification may reduce symptom-related stigma. Methods: Thirty-eight CHR subjects were ascertained using standard measures from the Center of Prevention and Evaluation/New York State Psychiatric Institute/ Columbia University. Labeling-related measures adapted to the CHR group included "stereotype awareness and self-stigma" ("Stereotype awareness", "Stereotype Agreement", "Negative emotions [shame]"), and a parallel measure of "Negative emotions (shame)" for symptoms. These measures were examined in relation to symptoms of anxiety and depression, adjusting for core CHR symptoms (e.g. attenuated psychotic symptoms). Results: CHR participants endorsed awareness of mental illness stereotypes, but largely did not themselves agree with these stereotypes. Furthermore, CHR participants described more stigma associated with symptoms than they did with the risk-label itself. Shame related to symptoms was associated with depression, while shame related to the risk-label was associated with anxiety. Conclusion: Both stigma of the risk-label and of symptoms contribute to the experience of CHR individuals. Stereotype awareness was relatively high and labeling-related shame was associated with increased anxiety. Yet limited agreement with stereotypes indicated that labeling-related stigma had not fully permeated self-conceptions. Furthermore, symptom-related stigma appeared more salient overall and was linked with increased depression, suggesting that alleviating symptom-related shame via treating symptoms might provide major benefit.

Original languageEnglish (US)
Article number6492
Pages (from-to)9-15
Number of pages7
JournalSchizophrenia Research
Volume168
Issue number1-2
DOIs
StatePublished - Oct 1 2015

Fingerprint

Psychotic Disorders
Shame
Anxiety
Depression
Emotions
Psychiatry

Keywords

  • Adolescents
  • At risk
  • Clinical high risk state for psychosis
  • Discrimination
  • Early psychosis
  • Prodrome
  • Stigma

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Yang, L., Link, B. G., Ben-David, S., Gill, K. E., Girgis, R. R., Brucato, G., ... Corcoran, C. M. (2015). Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis. Schizophrenia Research, 168(1-2), 9-15. [6492]. https://doi.org/10.1016/j.schres.2015.08.004

Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis. / Yang, Larry; Link, Bruce G.; Ben-David, Shelly; Gill, Kelly E.; Girgis, Ragy R.; Brucato, Gary; Wonpat-Borja, Ahtoy J.; Corcoran, Cheryl M.

In: Schizophrenia Research, Vol. 168, No. 1-2, 6492, 01.10.2015, p. 9-15.

Research output: Contribution to journalArticle

Yang, L, Link, BG, Ben-David, S, Gill, KE, Girgis, RR, Brucato, G, Wonpat-Borja, AJ & Corcoran, CM 2015, 'Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis', Schizophrenia Research, vol. 168, no. 1-2, 6492, pp. 9-15. https://doi.org/10.1016/j.schres.2015.08.004
Yang, Larry ; Link, Bruce G. ; Ben-David, Shelly ; Gill, Kelly E. ; Girgis, Ragy R. ; Brucato, Gary ; Wonpat-Borja, Ahtoy J. ; Corcoran, Cheryl M. / Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis. In: Schizophrenia Research. 2015 ; Vol. 168, No. 1-2. pp. 9-15.
@article{30b1978e384a42839fe372de36d2755c,
title = "Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis",
abstract = "Background: Despite advances that the psychosis {"}clinical high-risk{"} (CHR) identification offers, risk of stigma exists. Awareness of and agreement with stereotypes has not yet been evaluated in CHR individuals. Furthermore, the relative stigma associated with symptoms, as opposed to the label of risk, is not known, which is critical because CHR identification may reduce symptom-related stigma. Methods: Thirty-eight CHR subjects were ascertained using standard measures from the Center of Prevention and Evaluation/New York State Psychiatric Institute/ Columbia University. Labeling-related measures adapted to the CHR group included {"}stereotype awareness and self-stigma{"} ({"}Stereotype awareness{"}, {"}Stereotype Agreement{"}, {"}Negative emotions [shame]{"}), and a parallel measure of {"}Negative emotions (shame){"} for symptoms. These measures were examined in relation to symptoms of anxiety and depression, adjusting for core CHR symptoms (e.g. attenuated psychotic symptoms). Results: CHR participants endorsed awareness of mental illness stereotypes, but largely did not themselves agree with these stereotypes. Furthermore, CHR participants described more stigma associated with symptoms than they did with the risk-label itself. Shame related to symptoms was associated with depression, while shame related to the risk-label was associated with anxiety. Conclusion: Both stigma of the risk-label and of symptoms contribute to the experience of CHR individuals. Stereotype awareness was relatively high and labeling-related shame was associated with increased anxiety. Yet limited agreement with stereotypes indicated that labeling-related stigma had not fully permeated self-conceptions. Furthermore, symptom-related stigma appeared more salient overall and was linked with increased depression, suggesting that alleviating symptom-related shame via treating symptoms might provide major benefit.",
keywords = "Adolescents, At risk, Clinical high risk state for psychosis, Discrimination, Early psychosis, Prodrome, Stigma",
author = "Larry Yang and Link, {Bruce G.} and Shelly Ben-David and Gill, {Kelly E.} and Girgis, {Ragy R.} and Gary Brucato and Wonpat-Borja, {Ahtoy J.} and Corcoran, {Cheryl M.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.schres.2015.08.004",
language = "English (US)",
volume = "168",
pages = "9--15",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis

AU - Yang, Larry

AU - Link, Bruce G.

AU - Ben-David, Shelly

AU - Gill, Kelly E.

AU - Girgis, Ragy R.

AU - Brucato, Gary

AU - Wonpat-Borja, Ahtoy J.

AU - Corcoran, Cheryl M.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Despite advances that the psychosis "clinical high-risk" (CHR) identification offers, risk of stigma exists. Awareness of and agreement with stereotypes has not yet been evaluated in CHR individuals. Furthermore, the relative stigma associated with symptoms, as opposed to the label of risk, is not known, which is critical because CHR identification may reduce symptom-related stigma. Methods: Thirty-eight CHR subjects were ascertained using standard measures from the Center of Prevention and Evaluation/New York State Psychiatric Institute/ Columbia University. Labeling-related measures adapted to the CHR group included "stereotype awareness and self-stigma" ("Stereotype awareness", "Stereotype Agreement", "Negative emotions [shame]"), and a parallel measure of "Negative emotions (shame)" for symptoms. These measures were examined in relation to symptoms of anxiety and depression, adjusting for core CHR symptoms (e.g. attenuated psychotic symptoms). Results: CHR participants endorsed awareness of mental illness stereotypes, but largely did not themselves agree with these stereotypes. Furthermore, CHR participants described more stigma associated with symptoms than they did with the risk-label itself. Shame related to symptoms was associated with depression, while shame related to the risk-label was associated with anxiety. Conclusion: Both stigma of the risk-label and of symptoms contribute to the experience of CHR individuals. Stereotype awareness was relatively high and labeling-related shame was associated with increased anxiety. Yet limited agreement with stereotypes indicated that labeling-related stigma had not fully permeated self-conceptions. Furthermore, symptom-related stigma appeared more salient overall and was linked with increased depression, suggesting that alleviating symptom-related shame via treating symptoms might provide major benefit.

AB - Background: Despite advances that the psychosis "clinical high-risk" (CHR) identification offers, risk of stigma exists. Awareness of and agreement with stereotypes has not yet been evaluated in CHR individuals. Furthermore, the relative stigma associated with symptoms, as opposed to the label of risk, is not known, which is critical because CHR identification may reduce symptom-related stigma. Methods: Thirty-eight CHR subjects were ascertained using standard measures from the Center of Prevention and Evaluation/New York State Psychiatric Institute/ Columbia University. Labeling-related measures adapted to the CHR group included "stereotype awareness and self-stigma" ("Stereotype awareness", "Stereotype Agreement", "Negative emotions [shame]"), and a parallel measure of "Negative emotions (shame)" for symptoms. These measures were examined in relation to symptoms of anxiety and depression, adjusting for core CHR symptoms (e.g. attenuated psychotic symptoms). Results: CHR participants endorsed awareness of mental illness stereotypes, but largely did not themselves agree with these stereotypes. Furthermore, CHR participants described more stigma associated with symptoms than they did with the risk-label itself. Shame related to symptoms was associated with depression, while shame related to the risk-label was associated with anxiety. Conclusion: Both stigma of the risk-label and of symptoms contribute to the experience of CHR individuals. Stereotype awareness was relatively high and labeling-related shame was associated with increased anxiety. Yet limited agreement with stereotypes indicated that labeling-related stigma had not fully permeated self-conceptions. Furthermore, symptom-related stigma appeared more salient overall and was linked with increased depression, suggesting that alleviating symptom-related shame via treating symptoms might provide major benefit.

KW - Adolescents

KW - At risk

KW - Clinical high risk state for psychosis

KW - Discrimination

KW - Early psychosis

KW - Prodrome

KW - Stigma

UR - http://www.scopus.com/inward/record.url?scp=84942363596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942363596&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2015.08.004

DO - 10.1016/j.schres.2015.08.004

M3 - Article

VL - 168

SP - 9

EP - 15

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-2

M1 - 6492

ER -